PEOPLE - CardioGenesis makes appointment:
This article was originally published in Clinica
Joseph Kletzel II has been appointed senior vice-president and general manager of CardioGenesis' pacific division, effective immediately. He has been a member of the board of directors for three years and will continue to serve on the board. He joins the cardiovascular disease device company, based in Foothill Ranch, California, from human tissue engineering firm Advanced Tissue Sciences.
You may also be interested in...
GSK creates another partnership centered on its vaccine adjuvant technology, this time with China's Xiamen Innovax.
Lab testing for COVID-19 has risen to a new high of 314,000 tests per week in Germany, where the concerns are perhaps less about test availability than staff numbers to oversee the testing protocols.
A new European Commission guidance document explains the regulatory basics and much- altered emergency market entry criteria for new entrants to devices sector amid the COVID-19 crisis.